Brieflands
Journal finderSearch
·
Sign in

Innovative Journal of Pediatrics

The Scientific Journal of Growth & Development Research Center

e-ISSN 3117-5341
Home
Articles
    Accepted ManuscriptsCurrent IssueAll IssuesIn Press ArticlesSearch
Instructions
About Journal
    Journal InformationBoards and CommitteesIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormAnnouncementSupportContact Us
APC
Authors GuideSubmit manuscript
  1. Brieflands
  2. /
  3. journals
  4. /
  5. Innovative Journal of Pediatrics
  6. /
  7. Articles
  8. /
  9. Transfusion-Associated HIV Infection in Pediatric Leukemia Patients (Two Case Reports)
  10. /
  11. Scopus by Title (Ref)
Citation data

Scopus by Title (Ref)

Articles that cite the referenced work, matched by title from the Scopus database.

5 results·Updated October 10, 2026
← Back to article
1

Post-transfusion complications in pediatric patients with Leukemia

Revista Cubana De Pediatria

January-March 2021

Pardo-Parra L.M.

2

α-Phellandrene alters expression of genes associated with DNA damage, cell cycle, and apoptosis in murine leukemia WEHI-3 cells

Anticancer Research

1 August 2014

Lin J.J.

3

Alpha-phellandrene, a natural active monoterpene, influences a murine WEHI-3 leukemia model in vivo by enhancing macrophague phagocytosis and natural killer cell activity

In Vivo

1 July 2014

Lin J.J.

4

Wogonin, a natural and biologically-active flavonoid, influences a murine WEHI-3 leukemia model in vivo through enhancing populations of T- And B-cells

In Vivo

November-December 2013

Lin C.C.

5

Epigallocatechin gallate (EGCG), influences a murine wehi-3 leukemia model in vivo through enhancing phagocytosis of macrophages and populations of t- and b-cells

In Vivo

September-October 2013

Huang A.C.

Need help?

Editorial, submission and technical questions all go to the same desk.

Submit a ticket
Brieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.